metabolic anti cancer drug (haim bio)

N/A

Report date: 2025/01/26 16:18:29
NME

Base Information

Drug Namemetabolic anti cancer drug (haim bio)
Drug Alias Namesolid tumor/blood cancer therapeutic (Haim bio)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsSolid tumoursHematologic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesHaim Bio Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesHaim Bio Co Ltd
Inactive CompaniesN/A
Active IndicationsSolid tumoursHematologic Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A